| 11/12/2026 3:54 PM | Pelthos Therapeutics (1919246) Subject | Form 425 | |
| 11/12/2026 6:40 AM | Pelthos Therapeutics (1919246) Filer | Form S-8 POS | |
| 11/12/2026 6:40 AM | Pelthos Therapeutics (1919246) Filer | Form S-8 POS | |
| 11/12/2026 6:41 AM | Pelthos Therapeutics (1919246) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/12/2026 6:16 AM | Pelthos Therapeutics (1919246) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2026 6:10 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/03/2026 7:20 PM | LIGAND PHARMACEUTICALS INC (886163) Filed by Pelthos Therapeutics (1919246) Subject | Form SCHEDULE 13D/A | |
| 10/30/2026 3:15 PM | Pelthos Therapeutics (1919246) Subject | Form 425 | |
| 10/30/2026 8:17 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2026 8:20 AM | Pelthos Therapeutics (1919246) Subject | Form 425 | |
| 10/06/2026 4:53 PM | Pauls Matthew (1573429) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PTHS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pelthos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/06/2026 4:53 PM | Friedberg Ezra M (1679440) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2026 4:54 PM | Greenleaf Peter (1363683) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2026 4:15 PM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2026 4:10 PM | Pelthos Therapeutics (1919246) Filer | Form ARS | |
| 08/18/2026 4:00 PM | Pelthos Therapeutics (1919246) Filer | Form DEF 14A | |
| 08/18/2026 4:05 PM | Pelthos Therapeutics (1919246) Filer | Form DEFA14A | |
| 08/13/2026 6:15 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 6:20 AM | Pelthos Therapeutics (1919246) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/13/2026 6:00 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 6:06 AM | Pelthos Therapeutics (1919246) Filer | Form 10-Q/A | |
| 08/07/2026 4:00 PM | Pelthos Therapeutics (1919246) Filer | Form PRE 14A | |
| 07/07/2026 4:03 PM | Greenleaf Peter (1363683) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 4:03 PM | Pauls Matthew (1573429) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 4:03 PM | Friedberg Ezra M (1679440) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:25 PM | Friedberg Ezra M (1679440) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:25 PM | Davis Todd C (1392029) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 4:01 PM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/26/2026 6:17 PM | Francis Knuettel II (1433316) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 11:46 AM | Francis Knuettel II (1433316) Reporting Pelthos Therapeutics (1919246) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/18/2026 5:11 PM | Friedberg Ezra M (1679440) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 6:08 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2026 6:06 AM | Pelthos Therapeutics (1919246) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 7:00 PM | 3i, LP (1841619) Filed by Pelthos Therapeutics (1919246) Subject | Form SCHEDULE 13G/A | |
| 04/20/2026 4:00 PM | GAY JOHN M. (1765684) Reporting Pelthos Therapeutics (1919246) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/14/2026 7:42 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/10/2026 4:04 PM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 4:01 PM | Greenleaf Peter (1363683) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 4:02 PM | Pauls Matthew (1573429) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 4:03 PM | Friedberg Ezra M (1679440) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 4:03 PM | Malamut Richard (1772168) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 04/01/2026 4:39 PM | Francis Knuettel II (1433316) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4/A | |
| 04/01/2026 4:42 PM | Baxter Richard B (2075922) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4/A | |
| 04/01/2026 4:42 PM | Pelthos Therapeutics (1919246) Issuer Rangarao Sai (2077227) Reporting | Form 4/A | |
| 04/01/2026 4:42 PM | Pauls Matthew (1573429) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4/A | |
| 04/01/2026 4:43 PM | Greenleaf Peter (1363683) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4/A | |
| 04/01/2026 4:44 PM | Pelthos Therapeutics (1919246) Issuer Plesha Scott M. (1726687) Reporting | Form 4/A | |
| 04/01/2026 4:44 PM | Malamut Richard (1772168) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4/A | |
| 04/01/2026 4:45 PM | Davis Todd C (1392029) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4/A | |
| 04/01/2026 4:45 PM | Friedberg Ezra M (1679440) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4/A | |
| 03/19/2026 5:37 AM | Pelthos Therapeutics (1919246) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/19/2026 5:39 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/09/2026 11:15 PM | Pelthos Therapeutics (1919246) Filer | Form EFFECT | |
| 02/05/2026 3:08 PM | 3i, LP (1841619) Filed by Pelthos Therapeutics (1919246) Subject | Form SCHEDULE 13G/A | |
| 02/02/2026 3:46 PM | Pelthos Therapeutics (1919246) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 01/13/2026 7:30 AM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:31 PM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 3:46 PM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/29/2025 3:15 PM | Einhorn Andrew J. (1560685) Reporting Pelthos Therapeutics (1919246) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/29/2025 3:16 PM | Einhorn Andrew J. (1560685) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 4:30 PM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 3:15 PM | LIGAND PHARMACEUTICALS INC (886163) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 3:15 PM | Pelthos Therapeutics (1919246) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 4:01 PM | Pauls Matthew (1573429) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 11:37 AM | Friedberg Ezra M (1679440) Reporting Pelthos Therapeutics (1919246) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 7:30 AM | Pelthos Therapeutics (1919246) Filer | Form DEF 14A | |